Cue Biopharma focuses on developing a biologic treatment for wide range of diseases including cancers and autoimmune diseases.
Business Model:
Revenue: $9.3M
Employees: 51-200
Address: 40 Guest Street
City: Boston
State: MA
Zip: 02135
Country: US
Cue Biopharma focuses on developing a biologic treatment for wide range of diseases including cancers and autoimmune diseases.
Contact Phone:
+16179492680
Contact Email:
Listed Exchange:
NASDAQ
IPO Date:
1/2/2018
Ticker Symbol:
CUE
IPO Price:
$7.5/share
Amount Raised:
$66M
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 1/2018 | IPO | $66.2M | 1/2017 | Series B | 1 | $16.4M |
MDB Capital Group MDB Capital Group MDB Capital Group MDB Capital Group |
11/2022 | Post-IPO Equity | $30M | 12/2016 | Equity | $16.4M |
MDB Capital Group |
1/2015 | Series A | 1 | $10M |
MDB Capital Group MDB Capital Group MDB Capital Group MDB Capital Group |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|